134P Unmasking actionable mutations in HR+/HER2–metastatic breast cancer: Real-world insights from Avida DNA OncoLiquid BiopsyNGS combined with methylation indexFederica Bini, A. Zambelli, Rita De Sanctis et al.|ESMO Open|2025Cited by 0